You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Article metrics

Article menu

Download PDFPDF

XML
Emerging Technologies, Pharmacology and Therapeutics
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

 

Online download statistics by month:

Online download statistics by month: September 2017 to August 2024

AbstractFullPdf
Sep 2017828223
Oct 201715215347
Nov 2017898919
Dec 2017616114
Jan 201863634
Feb 2018797514
Mar 2018929510
Apr 2018929127
May 201880858
Jun 201854563
Jul 201857574
Aug 201848489
Sep 201822224
Oct 2018282812
Nov 2018424214
Dec 2018434322
Jan 201936356
Feb 201945437
Mar 2019393733
Apr 2019333212
May 2019201610
Jun 201922217
Jul 201930316
Aug 201932325
Sep 201921160
Oct 2019252513
Nov 2019313110
Dec 2019262614
Jan 202018186
Feb 202029275
Mar 202021214
Apr 202013131
May 202038396
Jun 202014142
Jul 202012132
Aug 202010104
Sep 202027285
Oct 202080796
Nov 202031328
Dec 2020323110
Jan 202114135
Feb 202132324
Mar 2021221910
Apr 2021444327
May 2021242411
Jun 2021383822
Jul 202116165
Aug 2021984
Sep 202112124
Oct 2021202018
Nov 2021202016
Dec 202113137
Jan 202224243
Feb 202211112
Mar 2022181710
Apr 202219192
May 2022181610
Jun 202222168
Jul 202221214
Aug 202220204
Sep 2022151510
Oct 202215154
Nov 2022282816
Dec 2022192114
Jan 202318172
Feb 202345394
Mar 202322226
Apr 202313139
May 2023191811
Jul 202319199
Aug 2023141211
Sep 2023151510
Oct 2023191811
Nov 202321185
Dec 202315151
Jan 2024554
Feb 202419199
Mar 2024222258
Apr 2024201916
May 202415128
Jun 2024181610
Jul 202429207
Aug 202421183
Total26322578830